Resource • Case Study
Shortening the pharmaceutical development lifecycle and reducing costs with IBM Clinical Development®
![Shortening the pharmaceutical development lifecycle and reducing costs with IBM Clinical Development®](https://biorasi.com/wp-content/uploads/AdobeStock_190342939-e1589819787904.jpg)
Overview:
Costs, overheard and time spent are factors Biorasi strives to reduce for its partners in complex clinical trials. IBM is the leading healthcare technology organization in the world. Recently, they wrote a case study on how Biorasi was able to remove the obstacles and optimize its efforts in running clinical trials. As one o the first adopters of the IBM Watson Health technology, Biorasi continues to demonstrate the effectiveness of innovation within clinical trials around the globe.